Financing Drug Discovery for Orphan Diseases

While pharmaceutical R&D budgets grow larger, getting drug approval only gets harder—which may ultimately jeopardize financing for drug development. A proposed "megafund" financing method could be the answer, and its chances of success are likely to be even greater for orphan drug development.

Learn more about the 'megafund' (PDF, 173kb)

Email: